跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CY-20
首页
药物
CY-20
CY-20
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins
US 2008008683 A1
申请人: ROUSSY INST GUSTAVE
优先权: 2004
US
Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
US 2005143385 A1
申请人: WATKINS CLARE J
优先权: 2004
US
Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors
US 2006058282 A1
申请人: FINN PAUL W
优先权: 2005
US
Traditional Chinese medicinal composition for treating neurasthenia and insomnia, and preparation method thereof
CN 105998932 A
申请人: LI LINGLING
优先权: 2016
CN
Chinese herbal medicinal component and preparation method of health care liquor for treating allergic dermatitis
CN 105998450 A
申请人: LI LINGLING
优先权: 2016
CN
Triarylamine organic compound for organic electroluminescent device and organic electroluminescent device
CN 115700245 A
申请人: BEIJING ETERNAL MAT TECH CO LTD
优先权: 2021
CN
化合物及其在有机电致发光显示器件中的应用
CN 113582854 B
申请人: 上海钥熠电子科技有限公司
优先权: 2021
CN
METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE, COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, AND METHOD FOR PRODUCING NITROGEN-CONTAINING COMPOUND
WO 2026004498 A1
申请人: JSR CORP
优先权: 2024
WO
药物
反馈